Page 16 - Initial Public Offerings Ipos

It's a green 2020 for IPOs: All 14 listings are trading above issue price

V Jayasankar, senior executive director and head of equity capital markets, Kotak Investment Banking, says the huge listing day pop is partly because of technical factors.

IPO fundraising more than doubles to Rs 45,000 crore in 2020: KIB

The companies had raised Rs 20,300 crore through IPO route in 2019

Airbnb hosts see windfall in just few hours from wild listing-day gains

Airbnb reserved $238 million worth of stock for its hosts, according to company filings

The current IPO craze is starting to look like tech bubble of late 1990s

The FTSE Renaissance Global IPO Index, which tracks the performance of offerings worldwide, is up 82 per cent this year, compared with a 12 per cent gain for MSCI's all-country equity index

Mrs Bectors' Rs 540-cr IPO to open for subscription on December 15

The issue comprises of Rs 40 crore of fresh capital raise and Rs 500 crore of secondary share sale by four existing shareholders

Sebi's timely move

Lower public shareholding norms should help large IPOs

Gland Pharma makes strong market debut on Friday, stock rises 21%

The post-listing market capitalisation for the company stands at Rs 29,848 crore, helping it break into the top 10 valuable pharma firms in the country

What changes with IPO is cautious decision-making: RailTel's Puneet Chawla

In conversation with Shine Jacob, RailTel's Chairman and Managing Director PUNEET CHAWLA talks about how its business improved during Covid and the IPO road map

Indigo Paints files papers with market regulator Sebi for Rs 1,000-cr IPO

The IPO comprises fresh issuance of stocks aggregating to Rs 300 crore and an offer-for-sale of up to 5,840,000 equity shares by private equity firm Sequoia Capita

Gland Pharma's Rs 6,480-cr IPO sails through on institutional support

Institutional portion sees 6.4x subscription; HNIs, retail investors give issue a miss

China's move to halt Ant IPO could slash fintech giant's value by $140 bn

Ant faces more scrutiny, tougher China regulatory requirements

India's largest pharma IPO worth Rs 6,500 cr set to hit market next week

Fosun-owned Gland Pharma sets price band for its IPO at Rs 1,490-1,500 per share

China halts Jack Ma's $37-bn Ant Group IPO citing 'major issues'

Shanghai, HK postpone listing two days before trading

Equitas SFB shares close nearly 1% below IPO price on market debut

The stock listed at Rs 31, a decline of 6 per cent against the issue price on the BSE

Ant Group's Shanghai retail book listing 872 times oversubscribed

Ant is poised to raise about $17.2 billion on Shanghai's STAR Market and roughly the same in Hong Kong, shattering the record set by Saudi Arabian Oil Co

Reforms in IPO rules discussed with investors from US, says Sebi

Rising FPI registrations & inflows signify sustained interest of foreign investors in the Indian capital mkt, the regulator said

Jack Ma to become richer than Walmart heirs with mega Ant Group IPO

Ma's 8.8% stake is worth $27.4 billion based on the stock pricing in Hong Kong and Shanghai

Gland Pharma receives Sebi's go-ahead to launch IPO pegged at Rs 5,000 cr

Apart from the fresh issue, there is an offer for sale (OFS) of a little over 34 million shares as part of the IPO

IRFC files papers with Sebi to float IPO of over 1.78 bn shares

The net proceeds are proposed to be utilised towards augmenting the company's equity capital base to meet future capital requirements arising out of growth in business and general corporate purposes

IPO expenses likely to ease further this year, say industry players

Investment banking and legal fees, advertisement and marketing, listing fees and brokerage, and selling commission are the typical cost heads incurred by a company for an IPO